PROX1 and hepatocellular carcinoma: Another study of liver tumor found that PROX1 mRNA expression was highly variable among samples of normal, cirrhotic, HCC and cholangiocellular carcinoma (CCC) human liver specimens, specifically showing that expression was decreased in HCC and CCC liver samples relative to normal controls, and was stably elevated in HCC cell lines [21].